140
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting

, , , , , , , & ORCID Icon show all
Pages 105-116 | Received 06 Nov 2023, Accepted 25 Jan 2024, Published online: 05 Mar 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.